It's not uncommon for a patient with obsessive-compulsive disorder (OCD) to also have a tic disorder, or for someone with ...

There are many myths about what ADHD is and is not due to misinformation and misunderstanding about the diagnosis.

A groundbreaking study by the Psychiatric Genomics Consortium has revealed significant genetic overlap among 14 psychiatric ...

A new Ontario-based study has found a significant rise in prescriptions for stimulant medications used to treat attention-deficit/hyperactivity disorder (ADHD), particularly among adults and females.

Annual prescriptions for drugs to treat attention-deficit/hyperactivity disorder (ADHD) increased 157% in Ontario from 2015 ...

Lumos Labs has obtained a clearance from the FDA for its popular Lumosity brain training platform, greenlighting a version of ...

A large study has found increasing rates of common mental health conditions and drug dependency, but stable rates of autism ...

A recent study of nearly 400,000 patients found that people with attention-deficit/hyperactivity disorder (ADHD) who take stimulants face a small but notable risk of ...

A voluntary, nationwide recall of Lisdexamfetamine dimesylate capsules, a drug often used to treat Attention Deficit Hyperactivity Disorder (ADHD) in adults and children over 6, has been issued by the ...

PARSIPPANY, N.J. and TEL AVIV, Israel and PARIS, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (Euronext: MEDCL), announced today that the U.S. Food and Drug Administration (FDA) ...